Company intelligence / Profile preview

GreenBioAZ

Chandler, Arizona, United States

Ownership: Private
Development stage: Other

Overview

GreenBioAZ develops plant-derived monoclonal antibodies and vaccines against infectious diseases such as Zika and West Nile viruses; available public information indicates activity at the pre-clinical stage without disclosed human clinical trial results.

Therapeutic areas: Infectious Diseases
Modalities: Monoclonal antibodyVaccineProteinBiologic
Industry: Biotech

Partnerships

Halberd

Beyond the preview

Go deeper on GreenBioAZ.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GreenBioAZ.

Explore the full profile